We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria.
- Abstract
Based on information provided in editorial follow up, an updated Competing Interests statement is as follows: At the time of publication of this study, the probiotic formulation sold as VSL#3 was produced by Dupont/Danisco in the US. The correct reference is: Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, et al. (2012) Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR to Suppress Colitis. Claudio De Simone (CDS) is the inventor of this probiotic formulation (also known as the De Simone Formulation).
- Publication
PLoS ONE, 2022, Vol 17, Issue 9, p1
- ISSN
1932-6203
- Publication type
Academic Journal
- DOI
10.1371/journal.pone.0275512